Multiple Developments in 340B Contract Pharmacy Lawsuits
Drug maker Sanofi last week updated its lawsuit challenging federal 340B contract pharmacy requirements to poke holes in the government’s introduction of, in the government’s words, “over six thousand pages of complaints from covered entities” about Sanofi’s alleged overcharges for 340B covered outpatient drugs.